Oyster Point Pharma Inc. (OYST) NASDAQ

$10.25 -0.18 (-1.73%)

Market Cap: $272.89M

As of 12/01/21 04:00 PM EST. Market closed.

(OYST)

Oyster Point Pharma Inc. (OYST) NASDAQ

$10.25 -0.18 (-1.73%)

Market Cap: $272.89M

As of 12/01/21 04:00 PM EST. Market closed.

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry ... read more

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. In pre-clinical and clinical studies, OC-01 (varenicline) nasal spray was shown to have a novel mechanism of action via activation of the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the lacrimal functional unit. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
62
Address
.
KEY STATS
Open
$10.45
Previous Close
$10.43
Days Range
$10.09 - $10.68
52 week range
$9.86 - $25.89
Volume
206,408
Avg. Volume (30 days)
181,627
Market Cap
$272.89M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,163,861
Open
$10.45
Previous Close
$10.43
Days Range
$10.09 - $10.68
52 week range
$9.86 - $25.89
Volume
206,408
Avg. Volume (30 days)
181,627
Market Cap
$272.89M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,163,861

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OYSTER POINT PHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Lochner Daniel Chief Financial Officer Nov 01, 2021 Option Exercise $11.51 8,590 98,871 58,221 Nov 02, 2021, 05:49 PM
Nau Jeffrey President and CEO Oct 21, 2021 Option Exercise $1.02 50,000 51,000 110,898 Oct 22, 2021, 04:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 18, 2021 Sale $14.84 550,000 8,160,736 1,057,976 Oct 20, 2021, 04:38 PM
LINK WILLIAM J PHD Director Oct 18, 2021 Sale $14.84 550,000 8,160,736 1,057,976 Oct 20, 2021, 04:32 PM
Ozawa Clare Director Oct 18, 2021 Sale $14.84 550,000 8,160,736 1,057,976 Oct 20, 2021, 04:31 PM
Lochner Daniel Chief Financial Officer Sep 02, 2021 Option Exercise $11.51 7,500 86,325 49,631 Sep 07, 2021, 08:03 AM
Nau Jeffrey President and CEO Sep 01, 2021 Option Exercise $1.02 10,000 10,200 60,898 Sep 01, 2021, 06:00 PM
Lochner Daniel Chief Financial Officer Jul 28, 2021 Option Exercise $11.51 7,500 86,325 42,131 Jul 29, 2021, 05:05 PM
Nau Jeffrey President and CEO Apr 02, 2021 Option Exercise $1.02 10,000 10,200 50,898 Apr 02, 2021, 02:11 PM
Lochner Daniel Chief Financial Officer Feb 24, 2021 Option Exercise $11.51 9,109 104,845 34,631 Feb 26, 2021, 07:50 PM
Nau Jeffrey President and CEO Feb 19, 2021 Option Exercise $1.02 10,000 10,200 40,898 Feb 23, 2021, 08:13 PM
Lochner Daniel Chief Financial Officer Sep 25, 2020 Option Exercise $11.51 4,000 46,040 14,300 Sep 28, 2020, 06:12 PM
Lochner Daniel Chief Financial Officer Aug 11, 2020 Option Exercise $11.51 4,000 46,040 10,300 Aug 18, 2020, 06:18 PM
Lochner Daniel Chief Financial Officer Aug 11, 2020 Option Exercise $11.51 4,000 46,040 4,000 Aug 12, 2020, 08:32 PM
Snisarenko John Chief Commercial Officer Aug 10, 2020 Buy $25.97 4,000 103,880 7,000 Aug 11, 2020, 04:03 PM
Nau Jeffrey President and CEO Jul 28, 2020 Option Exercise $1.02 5,000 5,100 5,000 Jul 30, 2020, 07:37 PM
InvOpps GP IV, L.L.C. Director May 19, 2020 Buy $28.00 178,571 4,999,988 1,850,818 May 21, 2020, 05:00 PM
InvOpps GP IV, L.L.C. Director Nov 04, 2019 Buy $16.00 750,000 12,000,000 1,731,425 Nov 06, 2019, 04:30 PM
Snisarenko John Chief Commercial Officer Nov 04, 2019 Buy $16.00 3,000 48,000 3,000 Nov 05, 2019, 06:08 AM
Lochner Daniel Chief Financial Officer Nov 04, 2019 Buy $16.00 6,300 100,800 6,300 Nov 05, 2019, 06:08 AM
Nau Jeffrey President and CEO Nov 04, 2019 Buy $16.00 1,000 16,000 1,000 Nov 05, 2019, 06:05 AM
Vida Ventures, LLC 10% Owner Nov 04, 2019 Buy $16.00 185,000 2,960,000 963,468 Nov 04, 2019, 07:04 PM
Falcon Vision LLC 10% Owner Nov 04, 2019 Buy $16.00 155,000 2,480,000 1,039,622 Nov 04, 2019, 06:19 PM
KKR Fund Holdings L.P. 10% Owner Nov 04, 2019 Buy $16.00 155,000 2,480,000 1,039,622 Nov 04, 2019, 06:17 PM
New Enterprise Associates 14, L.P. 10% Owner Nov 04, 2019 Buy $16.00 935,000 14,960,000 5,925,287 Nov 04, 2019, 06:04 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 04, 2019 Buy $16.00 437,500 7,000,000 1,003,658 Nov 04, 2019, 05:58 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 04, 2019 Buy $16.00 125,000 2,000,000 2,561,888 Nov 04, 2019, 05:58 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 04, 2019 Buy $16.00 27,500 440,000 2,002,298 Nov 04, 2019, 05:58 PM
Ozawa Clare Director Nov 04, 2019 Buy $16.00 562,500 9,000,000 2,561,888 Nov 04, 2019, 05:54 PM
LINK WILLIAM J PHD Director Nov 04, 2019 Buy $16.00 27,500 440,000 2,002,298 Nov 04, 2019, 05:51 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Lochner Daniel Chief Financial Officer 11/01/2021 98,871
Nau Jeffrey President and CEO 10/21/2021 51,000
Versant Venture Capital VI, L.P. 10% Owner 10/18/2021 8,160,736
LINK WILLIAM J PHD Director 10/18/2021 8,160,736
Ozawa Clare Director 10/18/2021 8,160,736
Lochner Daniel Chief Financial Officer 09/02/2021 86,325
Nau Jeffrey President and CEO 09/01/2021 10,200
Lochner Daniel Chief Financial Officer 07/28/2021 86,325
Nau Jeffrey President and CEO 04/02/2021 10,200
Lochner Daniel Chief Financial Officer 02/24/2021 104,845
Nau Jeffrey President and CEO 02/19/2021 10,200
Lochner Daniel Chief Financial Officer 09/25/2020 46,040
Lochner Daniel Chief Financial Officer 08/11/2020 46,040
Lochner Daniel Chief Financial Officer 08/11/2020 46,040
Snisarenko John Chief Commercial Officer 08/10/2020 103,880
Nau Jeffrey President and CEO 07/28/2020 5,100
InvOpps GP IV, L.L.C. Director 05/19/2020 4,999,988
InvOpps GP IV, L.L.C. Director 11/04/2019 12,000,000
Snisarenko John Chief Commercial Officer 11/04/2019 48,000
Lochner Daniel Chief Financial Officer 11/04/2019 100,800
Nau Jeffrey President and CEO 11/04/2019 16,000
Vida Ventures, LLC 10% Owner 11/04/2019 2,960,000
Falcon Vision LLC 10% Owner 11/04/2019 2,480,000
KKR Fund Holdings L.P. 10% Owner 11/04/2019 2,480,000
New Enterprise Associates 14, L.P. 10% Owner 11/04/2019 14,960,000
Versant Venture Capital VI, L.P. 10% Owner 11/04/2019 7,000,000
Versant Venture Capital VI, L.P. 10% Owner 11/04/2019 2,000,000
Versant Venture Capital VI, L.P. 10% Owner 11/04/2019 440,000
Ozawa Clare Director 11/04/2019 9,000,000
LINK WILLIAM J PHD Director 11/04/2019 440,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.10%
1Q
09/30/2021
03/31/2021
0.23%
2Q
09/30/2021
12/31/2020
7.69%
3Q
09/30/2021
06/30/2020
15.98%
5Q
09/30/2021
03/31/2020
21.61%
6Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.10%
1Q
03/31/2021
0.23%
2Q
12/31/2020
7.69%
3Q
06/30/2020
15.98%
5Q
03/31/2020
21.61%
6Q
Load More